These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37588747)

  • 1. Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma.
    Zhang Y; Wang G; Wang M
    Transl Cancer Res; 2023 Jul; 12(7):1684-1702. PubMed ID: 37588747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
    Shang BB; Chen J; Wang ZG; Liu H
    PeerJ; 2021; 9():e12315. PubMed ID: 34754620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
    Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
    [No Abstract]   [Full Text] [Related]  

  • 6. DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.
    Yang K; Nong J; Xie H; Wan Z; Zhou X; Liu J; Qin C; Luo J; Zhu G; Peng T
    J Cancer; 2024; 15(14):4668-4685. PubMed ID: 39006087
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
    Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.
    Xie H; Yang K; Qin C; Zhou X; Liu J; Nong J; Luo J; Wei Y; Hua H; Han C; Liao X; Yang C; Su H; Zhu G; Ye X; Peng T
    J Cancer; 2024; 15(1):149-165. PubMed ID: 38164283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Liu J; Liu T; Zhang C; He J; Zhou D; Wang Z; Wang R
    Front Genet; 2022; 13():992343. PubMed ID: 36276981
    [No Abstract]   [Full Text] [Related]  

  • 11. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 13. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
    Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
    Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
    [No Abstract]   [Full Text] [Related]  

  • 14. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
    Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
    Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic biomarker:
    Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
    Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
    Liu R; Wang G; Zhang C; Bai D
    World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
    Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
    Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
    Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
    Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
    Front Surg; 2022; 9():836080. PubMed ID: 35392063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.